Please enable JavaScript to continue using this application.

Compare $RLYB vs $SERA | Chartloom

Compare

$RLYB vs $SERA

Rallybio Corp · Sera Prognostics Inc

RLYB

Rallybio Corp

SERA

Sera Prognostics Inc

Compare $RLYB vs $SERA

Comparing Rallybio Corp and Sera Prognostics Inc

RLYBRallybio Corp

SERASera Prognostics Inc

RLYBRallybio Corp

Market cap

$90M

P/E (TTM)

2.17x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-15.1%

YTD performance

200.8%

52W performance

269.6%

FCF yield

29.6%

SERASera Prognostics Inc

Market cap

$80M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

89.94x

Rev growth (TTM)

-35.2%

YTD performance

-32.0%

52W performance

-35.2%

FCF yield

-35.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RLYB

SERA

Detailed metrics comparison

RLYB

Rallybio Corp

SERA

Sera Prognostics Inc

Market Cap

RLYB$90M

SERA$80M

Enterprise Value

RLYB$-3M

SERA$75M

Price

RLYB$17.02

SERA$2.04

P/E Ratio

RLYB2.17x

SERAN/A

P/S Ratio

RLYB139.64x

SERA1,141.23x

EV/Sales

RLYB-4.09x

SERA1,078.41x

EV/EBITDA

RLYB-0.10x

SERA0.00x

P/B Ratio

RLYB0.96x

SERA1.39x

P/FCF Ratio

RLYB3.38x

SERAN/A

EV/FCF

RLYB-0.10x

SERA-2.68x

PEG Ratio

RLYBN/A

SERAN/A

Forward P/E (NTM)

RLYBN/A

SERAN/A

Forward P/S (NTM)

RLYBN/A

SERA89.94x

Revenue (TTM)

RLYB$646K

SERA$70K

Revenue Growth (YoY)

RLYB-15.1%

SERA-35.2%

Forward Rev Growth

RLYB499.1%

SERA791.9%

Gross Margin (TTM)

RLYB0.0%

SERA-150.0%

Operating Margin (TTM)

RLYB0.0%

SERA0.0%

EBITDA Margin (TTM)

RLYB-4284.8%

SERA-50200.0%

Net Margin (TTM)

RLYB7051.2%

SERA-47475.7%

FCF Margin (TTM)

RLYB4135.0%

SERA-40262.9%

Net Income (TTM)

RLYB$46M

SERA$-33M

FCF (TTM)

RLYB$27M

SERA$-28M

EPS (TTM)

RLYB$7.86

SERA-$0.66

ROE (TTM)

RLYB68.6%

SERA-4671.0%

ROA (TTM)

RLYB64.5%

SERA-3406.0%

ROIC (TTM)

RLYB68.6%

SERA-4671.0%

Cash

RLYB$93M

SERA$4M

Debt

RLYB$0

SERA$0

Net Cash/Debt

RLYB$93M

SERA$4M

Current Ratio (TTM)

RLYB27.26x

SERA1.98x

Quick Ratio (TTM)

RLYB27.01x

SERA1.91x

Debt/Equity (TTM)

RLYB0.00x

SERA0.00x

Debt/Assets (TTM)

RLYB0.0%

SERA0.0%

Interest Coverage (TTM)

RLYBN/A

SERAN/A

Net Debt/EBITDA (TTM)

RLYB0.00x

SERA0.00x

Beta

RLYB-0.75

SERA1.09

52W Performance

RLYB269.6%

SERA-35.2%

YTD Performance

RLYB200.8%

SERA-32.0%

% from 52W High

RLYB-3.2%

SERA-48.4%

% from 52W Low

RLYB363.7%

SERA30.8%

Asset Turnover (TTM)

RLYB0.01x

SERA0.00x

FCF Yield (TTM)

RLYB29.6%

SERA-35.3%

Earnings Yield (TTM)

RLYB50.5%

SERA-41.6%

Dividend Yield (TTM)

RLYBN/A

SERAN/A

Rule of 40

RLYB4,119.9

SERA-40,298.0

EV/GP/RG

RLYBN/A

SERAN/A

Ticker research

View RLYB research View SERA research

Metric	RLYB Rallybio Corp	SERA Sera Prognostics Inc
Market & Valuation
Market Cap	$90M	$80M
Enterprise Value	$-3M	$75M
Price	$17.02	$2.04
P/E Ratio	2.17x	N/A
P/S Ratio	139.64x	1,141.23x
EV/Sales	-4.09x	1,078.41x
EV/EBITDA	-0.10x	0.00x
P/B Ratio	0.96x	1.39x
P/FCF Ratio	3.38x	N/A
EV/FCF	-0.10x	-2.68x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	89.94x
Revenue & Growth
Revenue (TTM)	$646K	$70K
Revenue Growth (YoY)	-15.1%	-35.2%
Forward Rev Growth	499.1%	791.9%
Profitability
Gross Margin (TTM)	0.0%	-150.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4284.8%	-50200.0%
Net Margin (TTM)	7051.2%	-47475.7%
FCF Margin (TTM)	4135.0%	-40262.9%
Net Income (TTM)	$46M	$-33M
FCF (TTM)	$27M	$-28M
EPS (TTM)	$7.86	-$0.66
ROE (TTM)	68.6%	-4671.0%
ROA (TTM)	64.5%	-3406.0%
ROIC (TTM)	68.6%	-4671.0%
Financial Health
Cash	$93M	$4M
Debt	$0	$0
Net Cash/Debt	$93M	$4M
Current Ratio (TTM)	27.26x	1.98x
Quick Ratio (TTM)	27.01x	1.91x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.75	1.09
52W Performance	269.6%	-35.2%
YTD Performance	200.8%	-32.0%
% from 52W High	-3.2%	-48.4%
% from 52W Low	363.7%	30.8%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	29.6%	-35.3%
Earnings Yield (TTM)	50.5%	-41.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	4,119.9	-40,298.0
EV/GP/RG	N/A	N/A
Ticker research	View RLYB research	View SERA research

Valuation

P/E Ratio

RLYB

2.17x

P/S Ratio

RLYB

139.64x

SERA

1,141.23x

EV/FCF

SERA

-2.68x

RLYB

-0.10x

Growth & revenue

Revenue Growth TTM

RLYB

-15.1%

SERA

-35.2%

Forward Revenue Growth

SERA

791.9%

RLYB

499.1%

Profitability & performance

Gross Margin

RLYB

0.0%

SERA

-150.0%

ROE

RLYB

68.6%

SERA

-4671.0%

FCF Yield %

RLYB

29.6%

SERA

-35.3%

52-Week Performance

RLYB

269.6%

SERA

-35.2%

Detailed metrics comparison

RLYB

Rallybio Corp

SERA

Sera Prognostics Inc

Market Cap

RLYB$90M

SERA$80M

Enterprise Value

RLYB$-3M

SERA$75M

Price

RLYB$17.02

SERA$2.04

P/E Ratio

RLYB2.17x

SERAN/A

P/S Ratio

RLYB139.64x

SERA1,141.23x

EV/Sales

RLYB-4.09x

SERA1,078.41x

EV/EBITDA

RLYB-0.10x

SERA0.00x

P/B Ratio

RLYB0.96x

SERA1.39x

P/FCF Ratio

RLYB3.38x

SERAN/A

EV/FCF

RLYB-0.10x

SERA-2.68x

PEG Ratio

RLYBN/A

SERAN/A

Forward P/E (NTM)

RLYBN/A

SERAN/A

Forward P/S (NTM)

RLYBN/A

SERA89.94x

Revenue (TTM)

RLYB$646K

SERA$70K

Revenue Growth (YoY)

RLYB-15.1%

SERA-35.2%

Forward Rev Growth

RLYB499.1%

SERA791.9%

Gross Margin (TTM)

RLYB0.0%

SERA-150.0%

Operating Margin (TTM)

RLYB0.0%

SERA0.0%

EBITDA Margin (TTM)

RLYB-4284.8%

SERA-50200.0%

Net Margin (TTM)

RLYB7051.2%

SERA-47475.7%

FCF Margin (TTM)

RLYB4135.0%

SERA-40262.9%

Net Income (TTM)

RLYB$46M

SERA$-33M

FCF (TTM)

RLYB$27M

SERA$-28M

EPS (TTM)

RLYB$7.86

SERA-$0.66

ROE (TTM)

RLYB68.6%

SERA-4671.0%

ROA (TTM)

RLYB64.5%

SERA-3406.0%

ROIC (TTM)

RLYB68.6%

SERA-4671.0%

Cash

RLYB$93M

SERA$4M

Debt

RLYB$0

SERA$0

Net Cash/Debt

RLYB$93M

SERA$4M

Current Ratio (TTM)

RLYB27.26x

SERA1.98x

Quick Ratio (TTM)

RLYB27.01x

SERA1.91x

Debt/Equity (TTM)

RLYB0.00x

SERA0.00x

Debt/Assets (TTM)

RLYB0.0%

SERA0.0%

Interest Coverage (TTM)

RLYBN/A

SERAN/A

Net Debt/EBITDA (TTM)

RLYB0.00x

SERA0.00x

Beta

RLYB-0.75

SERA1.09

52W Performance

RLYB269.6%

SERA-35.2%

YTD Performance

RLYB200.8%

SERA-32.0%

% from 52W High

RLYB-3.2%

SERA-48.4%

% from 52W Low

RLYB363.7%

SERA30.8%

Asset Turnover (TTM)

RLYB0.01x

SERA0.00x

FCF Yield (TTM)

RLYB29.6%

SERA-35.3%

Earnings Yield (TTM)

RLYB50.5%

SERA-41.6%

Dividend Yield (TTM)

RLYBN/A

SERAN/A

Rule of 40

RLYB4,119.9

SERA-40,298.0

EV/GP/RG

RLYBN/A

SERAN/A

Ticker research

View RLYB research View SERA research

Metric	RLYB Rallybio Corp	SERA Sera Prognostics Inc
Market & Valuation
Market Cap	$90M	$80M
Enterprise Value	$-3M	$75M
Price	$17.02	$2.04
P/E Ratio	2.17x	N/A
P/S Ratio	139.64x	1,141.23x
EV/Sales	-4.09x	1,078.41x
EV/EBITDA	-0.10x	0.00x
P/B Ratio	0.96x	1.39x
P/FCF Ratio	3.38x	N/A
EV/FCF	-0.10x	-2.68x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	89.94x
Revenue & Growth
Revenue (TTM)	$646K	$70K
Revenue Growth (YoY)	-15.1%	-35.2%
Forward Rev Growth	499.1%	791.9%
Profitability
Gross Margin (TTM)	0.0%	-150.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4284.8%	-50200.0%
Net Margin (TTM)	7051.2%	-47475.7%
FCF Margin (TTM)	4135.0%	-40262.9%
Net Income (TTM)	$46M	$-33M
FCF (TTM)	$27M	$-28M
EPS (TTM)	$7.86	-$0.66
ROE (TTM)	68.6%	-4671.0%
ROA (TTM)	64.5%	-3406.0%
ROIC (TTM)	68.6%	-4671.0%
Financial Health
Cash	$93M	$4M
Debt	$0	$0
Net Cash/Debt	$93M	$4M
Current Ratio (TTM)	27.26x	1.98x
Quick Ratio (TTM)	27.01x	1.91x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.75	1.09
52W Performance	269.6%	-35.2%
YTD Performance	200.8%	-32.0%
% from 52W High	-3.2%	-48.4%
% from 52W Low	363.7%	30.8%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	29.6%	-35.3%
Earnings Yield (TTM)	50.5%	-41.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	4,119.9	-40,298.0
EV/GP/RG	N/A	N/A
Ticker research	View RLYB research	View SERA research